Pharmacie HOMEOPLANT SRL

Pharmacie HOMEOPLANT reported total assets of 299,283 € at the end of the 2025 financial year (annual accounts filed with the NBB on 02 Feb 2026).

Company number (CBE) 0536.599.248 · VAT BE0536599248
5020 Namur
active in Retail sale of pharmaceutical products (NACE 47730)
operating since 10 Jul 2013 (≈ 13 yrs)
Public Public page: latest year only. The score, history and details open with a free account. Create a free account
Idonis solidity score
EDCBA

The score of Pharmacie HOMEOPLANT shows with a free account.

See the score
Profile
SRL since 2013
Components
  • Summary? / 5
    • Balance sheet strength
    • Liquidity
    • Repayment capacity
    • Profitability
    • Trajectory
    • Compliance and register
  • Position in its sectorvs peers
  • Supplier creditat 30 d
  • Borrowing capacityborrowable
  • Valuationcentral

Visible once signed in: create your account, the 14-day Pro trial is free.

Detail

Key figures 2025

Net result79,950 €
Equity20,460 €
Cash151,207 €
EBITDA116,332 €
Total assets299,283 €
The line marks its sector median: 41.5% (1048 companies).

Change 2022 → 2025: Equity -87 % Total assets +8 %

Accounts of the company itself (not consolidated).

The full file covers 10 financial years; a free account shows 2. →

Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error

Pharmacie HOMEOPLANT's annual accounts

20252024202320222021
Net result79,950 €
Equity20,460 €
Cash151,207 €
EBITDA116,332 €
Total assets299,283 €

Filed annual accounts

  • Year ended 30 Jun 2025filed on 02 Feb 2026
  • Year ended 30 Jun 2024filed on 06 Jan 2025
  • Year ended 30 Jun 2023filed on 22 Jan 2024
  • Year ended 30 Jun 2022filed on 20 Dec 2022
  • Year ended 30 Jun 2021filed on 27 Jan 2022

Pharmacie HOMEOPLANT's financial analysis

Management and control of Pharmacie HOMEOPLANT

1 active director(s) in the register.

Pharmacie HOMEOPLANT's shareholders and holdings →

Pharmacie HOMEOPLANT's publications in the Belgian Gazette

Company number, VAT number and registered office

Company number (CBE)
0536.599.248
VAT number
BE0536599248
Peppol
Registered · 0208:0536599248 · as of 10 Nov 2026
Legal form
SRL
Incorporated
10 Jul 2013
Registered office
5020 Namur
Latest accounts
2025 · filed on 02 Feb 2026
Activity
Retail sale of pharmaceutical products (NACE 47730)

Pharmacie HOMEOPLANT (SRL) has been based in Namur since 2013, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 79,950 € and equity of 20,460 €; its revenue is not published.

Guide: Reading Belgian SME accounts: the five figures that count →

Companies similar to Pharmacie HOMEOPLANT

Companies in the same business, of comparable size and area, outside its group.

Frequently asked questions about Pharmacie HOMEOPLANT

What is the revenue of Pharmacie HOMEOPLANT?

Pharmacie HOMEOPLANT files its accounts in a format where revenue is optional: it is not published for 2025.

What is the VAT number of Pharmacie HOMEOPLANT?

In Belgium, the VAT number is the company number prefixed with BE: BE0536599248 for Pharmacie HOMEOPLANT, if the company is VAT-registered. Its company number (CBE) is 0536.599.248.

Where is the registered office of Pharmacie HOMEOPLANT?

According to the CBE register, the registered office of Pharmacie HOMEOPLANT is in 5020 Namur.

What is the equity of Pharmacie HOMEOPLANT?

At the close of the 2025 financial year, the equity of Pharmacie HOMEOPLANT amounts to 20,460 €, a solvency of 6.8% of total assets.

Who manages Pharmacie HOMEOPLANT?

The register lists 1 active mandates at Pharmacie HOMEOPLANT. Names and roles are in the full file, with the deeds published in the Belgian Gazette.

Idonis

The full file of Pharmacie HOMEOPLANT

Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.

Open the full file →
Free account in 30 seconds, by email. No bank card.
Sources : Annual accounts — NBB ↗ Register — CBE ↗ Deeds — Belgian Gazette ↗ · Updated on 10 Jul 2026

No credit card, no commitment.

What each plan unlocks →